Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Engineered respiratory syncytial viruses with control of cell-to-cell virus transmission for enhanced safety of live virus vaccines

Engineered respiratory syncytial viruses with control of cell-to-cell virus transmission for enhanced safety of live virus vaccines

US Patent 10844357 · Granted Nov 24, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

RSV vaccines and methods of production and use thereof2024
RSV vaccines and methods of production and use thereof2022
RSV vaccines and methods of production and use thereof2020
Recombinant viruses of the paramyxoviridae family with heterologous envelope gly2009